Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 5,000 shares at $45.26 ($227K) on 2021-03-01, disclosed to the SEC on 2021-03-01.
Open-market sale of $227k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.26 | 4,500 | $204K | 89.8% |
| 2 | $46.08 | 500 | $23K | 10.2% |
| Total | $45.34 avg | 5,000 | $227K | 100% |
| Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |
| HALO | SELL | 2020-12-02 | $1.3M | — | Filing → |